Home Carboxes 21256-18-8
21256-18-8,MFCD00215977
Catalog No.:AA003I05
21256-18-8 | 3-(diphenyl-1,3-oxazol-2-yl)propanoic acid
Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
98+%
in stock  
$22.00   $15.00
- +
1g
98%
in stock  
$36.00   $25.00
- +
5g
98%
in stock  
$86.00   $60.00
- +
25g
98%
in stock  
$286.00   $200.00
- +
100g
98%
in stock  
$953.00   $667.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Q & A
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA003I05
Chemical Name:
3-(diphenyl-1,3-oxazol-2-yl)propanoic acid
CAS Number:
21256-18-8
Molecular Formula:
C18H15NO3
Molecular Weight:
293.3166
MDL Number:
MFCD00215977
IUPAC Name:
3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid
InChI:
InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)
InChI Key:
OFPXSFXSNFPTHF-UHFFFAOYSA-N
SMILES:
OC(=O)CCc1nc(c(o1)c1ccccc1)c1ccccc1
EC Number:
244-296-1
UNII:
MHJ80W9LRB
Properties
Computed Properties
 
Complexity:
361  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
293.105g/mol
Formal Charge:
0
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
293.322g/mol
Monoisotopic Mass:
293.105g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
63.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.2  

Synonyms
 
4,5 Diphenyl 2 oxazolepropionic Acid 
4,5-diphenyl-2-oxazolepropionic acid 
Wy 21,743 
BPBio1_001122 
GTPL7252 
Oxaprozin (JP17/USAN/INN) 
DTXSID1045118 
CTK7J3117 
HMS566H22 
HSDB 7586 
KBio3_001916 
KS-00000ULR 
HMS1571C22 
Wy-21,743 
HMS1922P17 
HMS2051L15 
HMS2093O08 
HMS2098C22 
HMS3262N10 
HMS3393L15 
HMS3652H17 
HMS3715C22 
Pharmakon1600-01505267 
Wy21743 
oxaprozin 
BCP28431 
HY-B0808 
Tox21_110059 
Tox21_500944 
2-Oxazolepropanoic acid,5-diphenyl- 
2-Oxazolepropionic acid,5-diphenyl- 
ANW-63377 
BDBM50002861 
CCG-36508 
NCGC00014711 
21256-18-8 
NSC758949 
s4230 
SBB053166 
ZINC49643479 
4,5-diphenyloxazole-2-propanoic acid 
4,5-Diphenyloxazole-2-propionic acid 
AKOS000206807 
Oxaprozin [USAN:USP:INN:BAN:JAN] 
Tox21_110059_1 
CS-7975 
Daypro 
DB00991 
KS-5196 
LP00944 
MCULE-7099031811 
NC00214 
NSC-758949 
NCGC00014711-01 
NCGC00014711-02 
NCGC00014711-03 
NCGC00014711-04 
Alvo 
NCGC00014711-05 
NCGC00014711-06 
NCGC00014711-07 
NCGC00014711-08 
NCGC00014711-09 
NCGC00014711-10 
NCGC00014711-11 
NCGC00014711-14 
NCGC00014711-15 
NCGC00094249-01 
Oxaprozine 
NCGC00094249-02 
NCGC00094249-03 
NCGC00094249-04 
NCGC00094249-05 
NCGC00094249-06 
NCGC00094249-07 
NCGC00261629-01 
AC-26512 
AJ-08102 
AK-84489 
Oxaprozinum 
CPD000058286 
NCI60_002681 
SAM001246770 
SC-13926 
SBI-0050918.P002 
AB0011812 
LS-100216 
TC-152122 
3-(4,5-Diphenyl-2-oxazolyl)propionic acid 
AB00514024 
3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid 
B1804 
EU-0100944 
FT-0638104 
O0377 
ST50949623 
SW197319-4 
3-(4, 5-Diphenyl-2-oxazolyl)propenoic acid 
EN300-25629 
3-(4,5-Diphenyl-oxazol-2-yl)-propionic acid 
4.5-Diphenyl-2-oxazolepropanoic acid|||Daypro 
3-(4,5-Diphenyloxazol-2-yl)propanoic acid 
C07356 
D00463 
J10396 
K-6109 
AB00514024_08 
AB00514024_09 
256O188 
A815225 
I14-8703 
J-013955 
Apo Oxaprozin 
Deflam 
SR-01000076053-1 
SR-01000076053-3 
SR-01000076053-7 
SR-01000076053-9 
3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid # 
BRD-K25394294-001-05-7 
BRD-K25394294-001-08-1 
Z217102860 
Oxaprozin, United States Pharmacopeia (USP) Reference Standard 
Duraprox 
Oxaprozina 
Apo-Oxaprozin 
Rhoxal-oxaprozin 
Apo Oxaprozin 
Rhoxal oxaprozin 
Daypro Alta 
lyl)propenoic acid 
Oxaprozin Potassium 
Duraprox (TN) 
CSC brand of oxaprozin 
TRB brand of oxaprozin 
Voir 
Apotex brand of oxaprozin 
Pfizer brand of oxaprozin 
D0M9DC 
Rhoxalpharma brand of oxaprozin 
3-(4, 5-Diphenyl-2-oxazo 
Oxaprozin (JP15/USAN/INN) 
CID4614 
4,5 Diphenyl 2 oxazolepropionic Acid 
CS-O-02038 
Wy 21,743 
Oxaprozine [INN-French] 
C008729 
D000077431 
Oxaprozin, 98%, a pancreatic and gastric lipase inhibitor and caspase-3 activator - 25G 25g 
Oxaprozinum [INN-Latin] 
WY-21743 
Oxaprozina [INN-Spanish] 
4,5-Diphenyl-2-oxazolepropionic acid 
WY-21,743 
4,5-Diphenyl-2-oxazolepropanoic acid 
Apo-Oxaprozin 
2-Oxazolepropanoic acid, 4,5-diphenyl- 
WY 21743 
NSC310839 
3-(4,5-Diphenyl-2-oxazolyl)propenoic acid 
beta-(4,5-Diphenyloxazol-2-yl)propionic acid 
UNII-MHJ80W9LRB 
MFCD00215977 
MHJ80W9LRB 
NSC 310839 
CHEMBL1071 
Danoprox 
CHEBI:7822 
3-(diphenyl-1,3-oxazol-2-yl)propanoic acid 
C18H15NO3 
2-OXAZOLEPROPIONIC ACID, 4,5-DIPHENYL- 
OFPXSFXSNFPTHF-UHFFFAOYSA-N 
.beta.-(4,5-Diphenyloxazol-2-yl)propionic acid 
EINECS 244-296-1 
NSC-310839 
BRN 1083168 
Danoprox 
Daypro 
Dayrun 
3-(4,5-Diphenyl-2-oxazolyl)propanoic acid 
CAS-21256-18-8 
DSSTox_CID_25118 
DSSTox_RID_80684 
DSSTox_GSID_45118 
Actirin 
Xopane 
SMR000058286 
Daypro (TN) 
Dayrun 
SR-01000076053 
oxaprosin 
Durapro 
Duraprost 
Oxaprozi 
Oxapro 
Walix 
Oxaprozin, solid 
Oxaprozin [USAN:BAN:INN:JAN] 
Oxaprozin,(S) 
oxaprozin 
NCI310839 
4, 5-Diphenyl-2-oxazolepropionic acid 
Maybridge1_008800 
Prestwick0_001060 
Prestwick1_001060 
Prestwick2_001060 
Prestwick3_001060 
Spectrum2_001696 
Spectrum3_001078 
Spectrum4_001231 
Rhoxal oxaprozin 
Lopac-O-9637 
O 9637 
AC1L1IK7 
SCHEMBL3286 
NCIStruc1_000799 
NCIStruc2_000787 
BIDD:PXR0149 
Lopac0_000944 
Oprea1_509470 
BSPBio_001020 
Rhoxal-oxaprozin 
BSPBio_002696 
KBioGR_001722 
MLS000759535 
MLS001424072 
BIDD:GT0438 
SPECTRUM1505267 
SPBio_001652 
SPBio_002940 
AC1Q759J 
AC1Q759K 
Literature

Title: Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

Journal: Chemical research in toxicology 20150518

Title: Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach.

Journal: European journal of medicinal chemistry 20120701

Title: Genetic toxicology and toxicogenomic analysis of three cigarette smoke condensates in vitro reveals few differences among full-flavor, blonde, and light products.

Journal: Environmental and molecular mutagenesis 20120501

Title: Synthesis, characterization and antiproliferative activity of transition metal complexes with 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid (oxaprozin).

Journal: Chemical & pharmaceutical bulletin 20120101

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology 20111201

Title: Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20110801

Title: Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: a toxicogenomic study.

Journal: Environmental and molecular mutagenesis 20110701

Title: The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.

Journal: Journal of biomedicine & biotechnology 20110101

Title: Characterization of a novel and spontaneous mouse model of inflammatory arthritis.

Journal: Arthritis research & therapy 20110101

Title: A predictive ligand-based Bayesian model for human drug-induced liver injury.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20101201

Title: Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

Journal: Healthcare informatics research 20101201

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Effect of ketorolac and diclofenac on the impairment of endothelium-dependent relaxation induced by reactive oxygen species in rabbit abdominal aorta.

Journal: Korean journal of anesthesiology 20100901

Title: Analgesic and anti-inflammatory effects of oxaprozin and naproxen sodium after removal of impacted lower third molars: a randomized, double-blind, placebo-controlled crossover study.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501

Title: Theoretical and vibrational studies of 4,5-diphenyl-2-2 oxazole propionic acid (oxaprozin).

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100401

Title: Testing for mean and correlation changes in microarray experiments: an application for pathway analysis.

Journal: BMC bioinformatics 20100101

Title: Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.

Journal: Journal of microencapsulation 20100101

Title: CK1epsilon is required for breast cancers dependent on beta-catenin activity.

Journal: PloS one 20100101

Title: Nonsteroidal Anti-Inflammatory Drugs: A survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data.

Journal: Pediatric rheumatology online journal 20100101

Title: Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.

Journal: Drug design, development and therapy 20100101

Title: Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions.

Journal: Clinical interventions in aging 20100101

Title: Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases.

Journal: BMC psychiatry 20100101

Title: Magnetic Fe₃O₄ nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells.

Journal: International journal of nanomedicine 20100101

Title: p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells.

Journal: PloS one 20100101

Title: Design, synthesis, and in-vivo evaluation of 4,5-diaryloxazole as novel nonsteroidal anti-inflammatory drug.

Journal: Biological & pharmaceutical bulletin 20091201

Title: Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Journal: Nature chemical biology 20091001

Title: Delayed apoptosis of human monocytes exposed to immune complexes is reversed by oxaprozin: role of the Akt/IkappaB kinase/nuclear factor kappaB pathway.

Journal: British journal of pharmacology 20090501

Title: Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways.

Journal: Journal of biomedicine & biotechnology 20090101

Title: Drugs associated with more suicidal ideations are also associated with more suicide attempts.

Journal: PloS one 20090101

Title: Development of a selective molecularly imprinted polymer-based solid-phase extraction for indomethacin from water samples.

Journal: Analytical and bioanalytical chemistry 20080801

Title: Topical ocular delivery of NSAIDs.

Journal: The AAPS journal 20080601

Title: Spread pattern of the first dengue epidemic in the city of Salvador, Brazil.

Journal: BMC public health 20080101

Title: Free drug metabolic clearance in elderly people.

Journal: Clinical pharmacokinetics 20080101

Title: Singlet oxygen scavenging activity of non-steroidal anti-inflammatory drugs.

Journal: Redox report : communications in free radical research 20080101

Title: The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells.

Journal: Cancer research 20070401

Title: In silico prediction of pregnane X receptor activators by machine learning approaches.

Journal: Molecular pharmacology 20070101

Title: Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis.

Journal: Arthritis research & therapy 20070101

Title: A peripatetic pediatrician's journey into pediatric rheumatology: Part II.

Journal: Pediatric rheumatology online journal 20070101

Title: The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy.

Journal: Pharmacoepidemiology and drug safety 20061201

Title: Studies on the interaction between Oxaprozin-E and bovine serum albumin by spectroscopic methods.

Journal: International journal of biological macromolecules 20061115

Title: Effects of isopropyl palmitate on the skin permeation of drugs.

Journal: Biological & pharmaceutical bulletin 20061101

Title: An exploratory theoretical elucidation on the peroxyl-radical-scavenging mechanism and structure-activity relationship of nonsteroidal anti-inflammatory drugs.

Journal: Bioorganic & medicinal chemistry letters 20060615

Title: Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes.

Journal: The Journal of pharmacy and pharmacology 20060101

Title: Analytic performance evaluation of a new turbidimetric immunoassay for phenytoin on the ADVIA 1650 analyzer: effect of phenytoin metabolite and analogue.

Journal: Therapeutic drug monitoring 20050601

Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.

Journal: Chemical research in toxicology 20050601

Title: A review of the emerging profile of the anti-inflammatory drug oxaprozin.

Journal: Expert opinion on pharmacotherapy 20050501

Title: Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs.

Journal: Life sciences 20050429

Title: Patient characteristics associated with outpatient prescriptions for nabumetone and oxaprozin versus celecoxib and rofecoxib.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050401

Title: Subjective impact of osteoarthritis flare-ups on patients' quality of life.

Journal: Health and quality of life outcomes 20050101

Title: In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs.

Journal: Free radical biology & medicine 20041201

Title: Oxaprozin: kinetic and dynamic profile in the treatment of pain.

Journal: Current medical research and opinion 20040801

Title: Oxaprozin versus diclofenac in NSAID-refractory periarthritis pain of the shoulder.

Journal: Current medical research and opinion 20040801

Title: The 'high solubility' definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs.

Journal: Pharmaceutical research 20040201

Title: Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin.

Journal: Drugs & aging 20040101

Title: [Meta-analysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritis treated with non-steroidal anti-inflammatory drugs].

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 20031101

Title: Identification and prediction of promiscuous aggregating inhibitors among known drugs.

Journal: Journal of medicinal chemistry 20031009

Title: The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.

Journal: The Journal of rheumatology 20031001

Title: Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells.

Journal: The Journal of pharmacology and experimental therapeutics 20020701

Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

Journal: The Journal of biological chemistry 20020419

Title: Pharmacological profile of oxaprozin eye drops.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20020201

Title: Nonsteroidal antiinflammatory drug-induced pseudoporphyria: a case series.

Journal: Journal of cutaneous medicine and surgery 20020101

Title: Search of antimicrobial activity of selected non-antibiotic drugs.

Journal: Acta poloniae pharmaceutica 20020101

Title: Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test.

Journal: Journal of pharmacokinetics and pharmacodynamics 20010601

Title: Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care.

Journal: Journal of the American Geriatrics Society 20010501

Title: A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis.

Journal: Journal of Tongji Medical University = Tong ji yi ke da xue xue bao 20010101

Title: Oxaprozin-induced symptomatic hepatotoxicity.

Journal: The Annals of pharmacotherapy 19990901

Title: Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells.

Journal: European journal of pharmacology 19980417

Title: Oxaprozin-induced fulminant hepatitis.

Journal: The Annals of pharmacotherapy 19941001

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Additional Info:
Q & A